SIK2 and ovarian carcinoma: Consistent with these clinical observations, we also showed that the forced expression of SIK2 enhances the metastatic ability of ovarian cancer cells in the intraperitoneal cavity, whereas SIK2 depletion prevents the formation of peritoneal disseminated tumors in in vivo mouse models.